Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Trying to raise capital in a down period for initial public stock offerings, Leap Therapeutics will conduct a reverse merger with publicly held Macrocure. As a result, Leap’s stock will be traded and Macrocure will become a subsidiary. The deal should give Leap $30 million to support development of its immuno-oncology antibodies. A week earlier, the regenerative medicine firm BioCardia agreed to do a reverse merger with Tiger X Medical. And PixarBio, a pain management company cofounded by MIT professor Robert Langer, is in the process of reverse merging with an undisclosed public firm.
This article has been sent to the following recipient: